Jefferies Group LLC Fibrogen Inc Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$11.4 - $14.6 $71,820 - $91,980	6,300 Added 21.95%	35,000 $455,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $399,000 - $511,000	35,000 New	35,000 $455,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $292,166 - $764,568	-28,700 Closed	0 $0
Q2 2021 Sep 21, 2023	SELL	$18.57 - $35.68 $116,991 - $224,784	-6,300 Reduced 18.0%	28,700 $764,000
Q2 2021 Aug 20, 2021	SELL	$18.57 - $35.68 $52.8 Million - $101 Million	-2,841,300 Reduced 99.0%	28,700 $764,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $53.3 Million - $102 Million	2,870,000 New	2,870,000 $764,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $46.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.